Accent Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Accent Therapeutics's estimated annual revenue is currently $5.2M per year.
- Accent Therapeutics's estimated revenue per employee is $77,500
- Accent Therapeutics's total funding is $103M.
Employee Data
- Accent Therapeutics has 67 Employees.
- Accent Therapeutics grew their employee count by -18% last year.
Accent Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | VP, Biological & Translational Sciences | Reveal Email/Phone |
4 | VP, Chemistry | Reveal Email/Phone |
5 | VP Pre-Clinical Development | Reveal Email/Phone |
6 | VP Program Leadership | Reveal Email/Phone |
7 | VP, Biology | Reveal Email/Phone |
8 | VP Translational Medicine | Reveal Email/Phone |
9 | VP Biology | Reveal Email/Phone |
10 | Senior Director, DMPK | Reveal Email/Phone |
Accent Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Accent Therapeutics?
Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.
keywords:N/A
$103M
Total Funding
67
Number of Employees
$5.2M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accent Therapeutics News
Revolution Labs will be the new home for Accent Therapeutics, which has committed to a 65k SF lease for its innovative cancer research...
Some of the players operating in the global RNA-targeted small molecules market are: ACCENT THERAPEUTICS, Anima Biotech Inc.,...
Accent Therapeutics, a Lexington, MA-based biopharmaceutical company developing breakthrough treatments for cancer patients, completed a $63m Series B financing. The round was led by EcoR1 Capital with participation by GV, AbbVie Ventures, The Mark Foundation for Cancer Research, NS Investment ...
Biopharmaceutical company Accent Therapeutics announced it has raised $63 million in Series B funding Biopharmaceutical company Accent Therapeutics announced it has raised $63 million in Series B funding led by EcoR1 Capital with participation by GV, AbbVie Ventures, The Mark Foundation for Can ...
Two years ago, Accent Therapeutics got off a $40 million series A to target RNA-modifying proteins in cancer; now, in the middle of a pandemic, it’s still managed to bring in a respectable $63 million second funding round. Sponsored by Agilent Technologies How would you like to win free bench ...
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.7M | 67 | 86% | N/A |
#2 | $15.3M | 67 | 16% | N/A |
#3 | N/A | 67 | 10% | N/A |
#4 | $7.5M | 67 | 6% | N/A |
#5 | $12.9M | 68 | -3% | N/A |